Abstract

The amount of biomedical literature has been increasing rapidly during the last decade. Text mining techniques can harness this large-scale data, shed light onto complex drug mechanisms, and extract relation information that can support computational polypharmacology. In this work, we introduce a fully corpus-based and unsupervised method which utilizes the MEDLINE indexed titles and abstracts to infer drug gene associations and assist drug repositioning. The method measures the Pointwise Mutual Information (PMI) between biomedical terms derived from the Gene Ontology and the Medical Subject Headings. Based on the PMI scores, drug and gene profiles are generated and candidate drug gene associations are inferred when computing the relatedness of their profiles. Results show that an Area Under the Curve (AUC) of up to 0.88 can be achieved. The method can successfully identify direct drug gene associations with high precision and prioritize them. Validation shows that the statistically derived profiles from literature perform as good as manually curated profiles. In addition, we examine the potential application of our approach towards drug repositioning. For all FDA approved drugs repositioned over the last 5years, we generate profiles from publications before 2009 and show that new indications rank high in the profiles. In summary, literature mined profiles can accurately predict drug gene associations and provide insights onto potential repositioning cases.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.